Beyond the composite: Differential impact of albumin and bilirubin relative to tumor burden in HCC
- 26 November 2025
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (2) , 111309
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Development and validation of the albumin-bilirubin gamma-glutamyl transferase score for enhanced prognostic accuracy after hepatocellular carcinoma resectionJournal of Gastrointestinal Surgery, 2025
- Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinomaJournal of Gastrointestinal Surgery, 2024
- The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysisHPB, 2024
- Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional AnalysisJournal of Gastrointestinal Surgery, 2023
- Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinomaHPB, 2023
- Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy OutcomesJournal of the American College of Surgeons, 2020
- Hepatocellular carcinoma tumour burden score to stratify prognosis after resectionBritish Journal of Surgery, 2020
- Prognostic utility of albumin‐bilirubin grade for short‐ and long‐term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi‐institutional analysis of 706 patientsJournal of Surgical Oncology, 2019
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinomaBritish Journal of Surgery, 2016